Literature DB >> 26306028

Using the electronic medical record to assess contraception usage among women taking category D or X medications.

Sheila K Mody1, John Paul Farala2, Jennifer Wu3, Robert Felix4, Christina Chambers4.   

Abstract

BACKGROUND: The aim of this study is to investigate contraceptive usage among women prescribed or currently taking a category D or X medication using the electronic medical record.
METHODS: This is a retrospective study assessing contraceptive usage among women prescribed category D or X medications. We obtained access to the electronic medical records of women seen in an academic Family Medicine Department between April 2011 and April 2012 who were prescribed a category D or X medication. Information was abstracted regarding the specific category D or X medication, demographics, sexual activity, sexual partner gender, and contraceptive usage.
RESULTS: There were a total of 610 women included in this study. Among the 610 women, 72 (11.8%) of women had documentation that they were not asked about their sexual activity. Sexual activity with men was documented in 407 of the 610 women (66.7%). Of these 407 women, 132 (32.4%) had no contraceptive method documented. Among the women using contraception, the most common method used was oral contraception.
CONCLUSION: According to data obtained from the electronic medical record, women who are taking a category D or X medication are not always asked about sexual activity. Contraception usage among women taking category D or X medications and who were sexually active with men was similar to the general population. Contraception usage should be better in this population given the risk of an unintended pregnancy includes fetal exposure to a potential teratogen. The electronic medical record creates an opportunity for an intervention to increase contraception utilization in this population.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Lacking

Mesh:

Substances:

Year:  2015        PMID: 26306028      PMCID: PMC4854287          DOI: 10.1002/bdra.23419

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  16 in total

Review 1.  Recent changes in pregnancy and lactation labeling: retirement of risk categories.

Authors:  Leda L Ramoz; Nima M Patel-Shori
Journal:  Pharmacotherapy       Date:  2014-01-04       Impact factor: 4.705

2.  Prescription of teratogenic medications in United States ambulatory practices.

Authors:  Eleanor Bimla Schwarz; Judith Maselli; Mary Norton; Ralph Gonzales
Journal:  Am J Med       Date:  2005-11       Impact factor: 4.965

3.  Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995.

Authors:  Jo Jones; William Mosher; Kimberly Daniels
Journal:  Natl Health Stat Report       Date:  2012-10-18

4.  Use of prescription medications with a potential for fetal harm among pregnant women.

Authors:  Susan E Andrade; Marsha A Raebel; Abraham N Morse; Robert L Davis; K Arnold Chan; Jonathan A Finkelstein; Kris K Fortman; Heather McPhillips; Douglas Roblin; David H Smith; Marianne Ulcickas Yood; Richard Platt; Jerry H Gurwitz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-08       Impact factor: 2.890

5.  Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women.

Authors:  Eleanor Bimla Schwarz; Debbie A Postlethwaite; Yun-Yi Hung; Mary Anne Armstrong
Journal:  Ann Intern Med       Date:  2007-09-18       Impact factor: 25.391

6.  Providing contraception for women taking potentially teratogenic medications: a survey of internal medicine physicians' knowledge, attitudes and barriers.

Authors:  David L Eisenberg; Catherine Stika; Ami Desai; David Baker; Kathleen J Yost
Journal:  J Gen Intern Med       Date:  2010-01-20       Impact factor: 5.128

7.  Women's perspectives on counseling about risks for medication-induced birth defects.

Authors:  Aimee K Santucci; Melanie A Gold; Aletha Y Akers; Sonya Borrero; Eleanor Bimla Schwarz
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-01

8.  Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-01-11       Impact factor: 17.586

Review 9.  Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks?

Authors:  Paul L Doering; Lisa A Boothby; Meyling Cheok
Journal:  Am J Obstet Gynecol       Date:  2002-08       Impact factor: 8.661

10.  Counseling of female veterans about risks of medication-induced birth defects.

Authors:  Eleanor Bimla Schwarz; Kristin Mattocks; Cynthia Brandt; Sonya Borrero; Laurie C Zephyrin; Harini Bathulapalli; Sally Haskell
Journal:  J Gen Intern Med       Date:  2013-07       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.